
Reset all filters
01 3Gadovist product family
Main Therapeutic Indication : Diagnostics
Currency : USD
2022 Revenue in Millions : 492
2021 Revenue in Millions : 460
Growth (%) : 7
Main Therapeutic Indication : Diagnostics
Currency : USD
2023 Revenue in Millions : 502
2022 Revenue in Millions : 492
Growth (%) : -1
Main Therapeutic Indication : Diagnostics
Currency : USD
2024 Revenue in Millions : 451
2023 Revenue in Millions : 502
Growth (%) : -10